Search
Niacin
go.drugbank.com/drugs/DB00627ApprovedInvestigationalNutraceuticalNiacin is a B vitamin used to treat vitamin deficiencies as well as hyperlipidemia, dyslipidemia, hypertriglyceridemia, and to reduce the risk of myocardial infarctions.
Mixtures: Niacin 500 Mg and Inositol, Vita Balance 2000Categories: Vitamin B ComplexXylometazoline
go.drugbank.com/drugs/DB06694ApprovedIn some countries, it is available as combination products with [ipratropium], [domiphen], or [dexpanthenol]. … [A228508] Xylometazoline is available in over-the-counter (OTC) nasal sprays or drops to temporarily relieve nasal congestion due to cold, hay fever or other respiratory allergies.
Mixtures: nasic - Nasenspray 10 mg/500 mg, nasic - Nasenspray für Kinder 5 mg/500 mgProducts: NASENSPRAY SINE AL 1MG/ML, NASENSPRAY SINE AL0.5MG/MLItraconazole
go.drugbank.com/drugs/DB01167ApprovedInvestigationalWhile the intravenous formulation of the drug was formerly available, it was discontinued in the US in 2007.[A263232] … [L50051] Itraconazole was first approved in the US in 1992 [L50056] and is available orally.
Mixtures: Ciclopirox 3% / Itraconazole 5% / Urea 20%, ITRACONAZOL 33.3 MG + SECNIDAZOL 166.66 MG CÁPSULAProducts: ITRACONAZOLO EG, SISTEMAZOL 200® CAPSULASDoxazosin
go.drugbank.com/drugs/DB00590ApprovedInvestigational[A180649] It is marketed by Pfizer and was initially approved by the FDA in 1990.[L7285] … Doxazosin is an alpha-1 antagonist used for the treatment of benign prostatic hypertrophy (BPH) symptoms and hypertension.
Categories: Drugs Used in Benign Prostatic HypertrophyProducts: DOXAZOSINA EG, DOXAZOSINA SUNCarboplatin
go.drugbank.com/drugs/DB00958ApprovedInvestigationalCarboplatin is an organoplatinum antineoplastic alkylating agent used in the treatment of advanced ovarian carcinoma.[L32253] Early clinical studies of carboplatin were performed in 1982. … [A230523] Carboplatin was developed as an analog of [cisplatin] with reduced nephrotoxicity and vomiting.[A230463,A230523] Carboplatin was granted FDA approval on 3 March 1989.[L32248]
Categories: Compounds used in a research, industrial, or household settingProducts: CARBOPLATINO SUN, PLATINWAS 150 MG 10MG/ML ENJ. FLAKON, 1 ADETAmikacin
go.drugbank.com/drugs/DB00479ApprovedInvestigationalVet approvedM. avium-intracellulare (MAC) is a type of nontuberculous mycobacteria (NTM) found in water and soil. … [F1949] In September 2018, a liposomal inhalation suspension of this drug was approved by the FDA for the treatment of lung disease caused by Mycobacterium avium complex (MAC) bacteria in a small population
Synonyms: 1-N-(L(−)-γ-amino-α-hydroxybutyryl)kanamycin A, -D-GLUCOPYRANOSYL-(1->4))-N(SUP 1)-(4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-, (S)-Products: AMIKACINA MK 250 MG/ML, AMIKETEM 250 MG/2 ML AMPUL, 1 ADETGlucosamine
go.drugbank.com/drugs/DB01296ApprovedOsteoarthritis (OA) is a progressive and degenerative joint disease marked by loss of cartilage, bone changes, and synovial membrane inflammation. Treatment with chondroprotective drugs, such as glucosamine sulfate may offer additional b...
Mixtures: Cartifit 200 mg/250 mg Hartkapseln, flexijoint 3-in-1 Joint Care PowderProducts: GLUCOSAMINA SOLFATO EG, FLEXTRIL® 500 MG CAPSULALercanidipine
go.drugbank.com/drugs/DB00528ApprovedInvestigationalWithdrawnLercanidipine is a calcium channel blocker of the dihydropyridine class. It is sold under various commercial names including Zanidip.
Mixtures: ZANIPRESS 20 MG/20 MG FILM TABLET,90 ADET, Zanipril 20 mg/20 mg FilmtablettenProducts: LERCANIDIPINA EG, Lercadip 20 mg FilmtablettenVon Willebrand factor human
go.drugbank.com/drugs/DB13133ApprovedInvestigationalThe human vWF is used to manage and control bleeding episodes in patients with von Willebrand disease and hemophilia A. It was first approved by the FDA in 2015. … [L40049] As vWF is normally present in the blood as a stable complex with coagulation factor III, therapeutic vWF products are also available as a combination product with [antihemophilic factor human]
Mixtures: BIOSTATE FOR INJECTION 50 iu/ml, FANHDI 250 U.I.Categories: von Willebrand factor and coagulation factor VIII in combinationNelarabine
go.drugbank.com/drugs/DB01280ApprovedInvestigational[A15220] Subsequently, nelarabine was also approved by both Health Canada and European Medicines Agency in 2007 under the trademark name ATRIANCE.[L45874,L45879] … [A258719] Nelarabine was first granted accelerated approval by the FDA on October 28, 2005, and was manufactured under the trademark name ARRANON by GlaxoSmithKline.
Products: NELARAMAX 250 MG/50 ML IV İNFÜZYONLUK ÇÖZELTİ , 6 ADET, NELARAMAX 250 MG/50 ML IV İNFÜZYONLUK ÇÖZELTİ , 1 ADET